Dr. Johnny Huard Honored with Caplan Award for His Innovations in Orthobiologics Research

Dr. Johnny Huard Honored with the Caplan Award for Distinguished Research in Orthobiologics

In a distinguished ceremony held in New Orleans on March 4, 2026, the American Academy of Orthopaedic Surgeons (AAOS) awarded Dr. Johnny Huard, PhD, with the prestigious Arnold I. Caplan Award. This significant accolade is designed to honor exceptional contributions to the field of orthobiologics, which utilizes biological materials and cells to enhance healing and repair within the musculoskeletal system, a branch of medicine that is increasingly pivotal in today's healthcare landscape.

Dr. Huard's name is now linked to that of Dr. Arnold Caplan, a pioneer in the field whose research extensively covered medicinal signaling cells (MSCs). This award not only pays tribute to Dr. Caplan’s legacy but also recognizes continued innovation in biologics-based solutions to treat musculoskeletal injuries and diseases.

For nearly thirty years, Dr. Huard has made remarkable strides in understanding adult stem cells and their implications for tissue recovery and regeneration. One of his key breakthroughs includes the identification of muscle-derived stem cells (MDSCs), which he successfully isolated from adult skeletal muscle. These stem cells possess properties typical of stem cells and are being widely used in regenerative medicine and tissue engineering to assist in the recovery of damaged, diseased, or aging tissues.

Currently serving as the Chief Scientific Officer and Director of the Linda Mitch Hart Center for Regenerative and Personalized Medicine at the Steadman Philippon Research Institute (SPRI) in Vail, Colorado, Dr. Huard has substantially influenced how MSCs function. He has shown that these therapeutic agents reside in blood vessels, reinforcing Dr. Caplan's assertion that all MSCs emerge as perivascular cells. Furthermore, Huard discovered that MSCs primarily accomplish their healing work through paracrine signaling—releasing critical bioactive substances that promote angiogenesis and regeneration. This finding has wide-ranging implications for future treatments in orthopaedic care.

Dr. Huard expresses gratitude for the recognition, stating, "Dr. Caplan challenged the field to rethink how mesenchymal stem cells function and how they contribute to tissue homeostasis and repair. Our work has provided essential biological insights that support his vision that MSCs' main role is signaling rather than simply replacement. Receiving an award in his name is truly a remarkable honor, as I continue to contribute to the growing body of knowledge in regenerative medicine."

Marc J. Philippon, MD, who chairs SPRI, noted Dr. Huard's commitment to advancing research, stating, "Dr. Huard has been an innovator in biologics research for over thirty years. The AAOS's recognition of his dedication illustrates how instrumental he has been in furthering regenerative medicine and improving patient outcomes."

The AAOS Committee on Devices, Biologics, and Technology Chair, Jason L. Dragoo, MD, also highlighted the far-reaching impact of Dr. Huard's work on both scientific understanding and patient care. He remarked, "Dr. Caplan set the foundation for understanding mesenchymal stem cells and their role in tissue repair. Dr. Huard's research has provided essential context to this vision, demonstrating MSCs as pericytes and propelling the Medicinal Signaling Cells concept. His studies reflect the innovative spirit crucial for advancing orthobiologics and enhancing patient outcomes."

The Arnold I. Caplan Award, funded by the Caplan family in association with the Orthopaedic Research and Education Foundation (OREF), not only symbolizes excellence in orthobiologics research but also includes a monetary prize of $10,000. The award signifies both recognition and encouragement for scientists to continue exploring innovative pathways to enrich the quality of patient care.

For more details on the research impact and contributions leading up to this honor, interested parties are encouraged to visit the AAOS website and explore ongoing initiatives aimed at advancing orthobiologics education and research.

About AAOS:
The American Academy of Orthopaedic Surgeons, with over 39,000 members, is the world's largest medical association dedicated to musculoskeletal specialists, ensuring they receive the education and resources needed to deliver the best patient care possible.

About OREF:
The Orthopaedic Research and Education Foundation (OREF), an independent nonprofit organization, is focused on improving clinical practices and patient outcomes through innovative research, supporting new investigators, and uniting the orthopaedic community for musculoskeletal health.